BlackRock Fund Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $112M | Buy |
4,444,772
+492,424
| +12% | +$12.4M | 0.02% | 1111 |
|
|
2016
Q3 | $97.7M | Buy |
3,952,348
+853,080
| +28% | +$21.1M | 0.02% | 1086 |
|
|
2016
Q2 | $63.1M | Buy |
3,099,268
+272,279
| +10% | +$5.55M | 0.01% | 1335 |
|
|
2016
Q1 | $43.1M | Buy |
2,826,989
+31,238
| +1% | +$476K | 0.01% | 1545 |
|
|
2015
Q4 | $37.6M | Sell |
2,795,751
-17,857
| -0.6% | -$240K | 0.01% | 1669 |
|
|
2015
Q3 | $39.5M | Buy |
2,813,608
+330,918
| +13% | +$4.64M | 0.01% | 1576 |
|
|
2015
Q2 | $42.2M | Buy |
2,482,690
+1,125,874
| +83% | +$19.1M | 0.01% | 1636 |
|
|
2015
Q1 | $16.4M | Buy |
1,356,816
+22,301
| +2% | +$270K | ﹤0.01% | 2171 |
|
|
2014
Q4 | $11.1M | Buy |
1,334,515
+120,602
| +10% | +$1M | ﹤0.01% | 2403 |
|
|
2014
Q3 | $10.5M | Buy |
1,213,913
+8,513
| +0.7% | +$74K | ﹤0.01% | 2314 |
|
|
2014
Q2 | $13.2M | Buy |
1,205,400
+229,881
| +24% | +$2.52M | ﹤0.01% | 2249 |
|
|
2014
Q1 | $8.72M | Buy |
975,519
+151,886
| +18% | +$1.36M | ﹤0.01% | 2476 |
|
|
2013
Q4 | $6.21M | Buy |
823,633
+70,057
| +9% | +$528K | ﹤0.01% | 2675 |
|
|
2013
Q3 | $5.52M | Buy |
753,576
+98,929
| +15% | +$725K | ﹤0.01% | 2742 |
|
|
2013
Q2 | $4.21M | Buy |
+654,647
| New | +$4.21M | ﹤0.01% | 2804 |
|